G6PD and cancer: Besides that, Saqcena et al. reported that DNA damaging agents selectively induce apoptosis in cancer cells arrested in the S and G2 phases of the cell cycle, implying that phase-specific cytotoxic drugs in combination with G6PD inhibitors may create synthetic lethality that can be a promising therapeutic approach in the combat against cancer [61].